The airborne transmission of SARS-CoV-2 has renewed interest in engineering controls for indoor air; photocatalytic oxidation over titanium dioxide (TiO2) under ultraviolet (UV) light is an attractive, reagent-free basis for such controls. Rational development requires a biosafe, quantifiable challenge organism usable at biosafety level 1 (BSL-1). We validated the thermophilic bacteriophage TP-84 (host Geobacillus stearothermophilus) as a surrogate for airborne viruses, characterising its stability, aerosolisation, recovery from photocatalytic supports and inactivation on TiO2 surfaces under UVA, UVC and UVA + UVC by a reference-normalised mass balance. TP-84 was stable in a simulated saliva matrix, survived ultrasonic nebulisation, and was recovered from porous ceramic supports at 66.0–91.7%. Five minutes of UV on TiO2 surfaces—UVC (254 nm, 540 mJ cm−2) or combined UVA + UVC (2040 mJ cm−2)—inactivated 87.4–89.4% and 61.6–76.5% of phage, respectively; bulk liquid was strongly protective (94.6–97.5% recovery), whereas desiccation reduced recovery to 4.3–16%. Flow-through aerosol assays provided a device test bed. Because TP-84 is a hardy, non-enveloped dsDNA virus, these values are conservative lower bounds that must not be equated with SARS-CoV-2 efficacy; validation with an enveloped surrogate and authentic virus is the next step.
No takes yet. Share an insight, caveat, or question.
Sobolewski et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: